fda compounding semaglutide warning 2025 october warns against compounded GLP-1 medications Novo Nordisk expands legal action

If you experience symptoms such as unusual tingling or numbness in hands or feet, difficulty walking, visual disturbances, or severe fatigue during pregnancy, seek prompt medical assessment as these may indicate B12 deficiency requiring treatment

Compounded semaglutide is often less expensive than brand-name products, but these medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing

Standardization promotes accurate billing, efficient processing, and alleviates disparities between healthcare settings by simplifying the processes

Type of Procedure: Non-invasive treatments

Five scales for older adults contained only positively phrased items